Challenges in development of targeted liposomal therapeutics. - Wikidata - wikimedia - TriplyDB

Challenges in development of targeted liposomal therapeutics.

Challenges in development of targeted liposomal therapeutics.

http://www.wikidata.org/entity/Q37993466

about

Advances and Challenges of Liposome Assisted Drug Delivery The potential of liposomes with carbonic anhydrase IX to deliver anticancer ingredients to cancer cells in vivo Toward a magic or imaginary bullet? Ligands for drug targeting to cancer cells: principles, hopes, and challenges Enhanced Specificity and Drug Delivery in Tumors by cRGD-Anchoring Thermosensitive Liposomes SapC-DOPS nanovesicles as targeted therapy for lung cancer Enhanced antitumor efficacy and reduced systemic toxicity of sulfatide-containing nanoliposomal doxorubicin in a xenograft model of colorectal cancer Multimeric disintegrin protein polymer fusions that target tumor vasculature.In vitro synergistic action of geldanamycin- and docetaxel-containing HPMA copolymer-RGDfK conjugates against ovarian cancer Targeted delivery of polyamidoamine-paclitaxel conjugate functionalized with anti-human epidermal growth factor receptor 2 trastuzumab Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery Research and development in drug innovation: reflections from the 2013 bioeconomy conference in China, lessons learned and future perspectives In vitro selection of random peptides against artificial lipid bilayers: a potential tool to immobilize molecules on membranes.Tumor neovasculature-targeted cationic PEGylated liposomes of gambogic acid for the treatment of triple-negative breast cancer GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy.Cholesterol--a biological compound as a building block in bionanotechnology.Magnetoliposomes and their potential in the intelligent drug-delivery field.Oligonucleotide conjugates for therapeutic applications.Current trends in the use of liposomes for tumor targeting Applications of nanotechnology for melanoma treatment, diagnosis, and theranostics.Liposomal chemotherapeutics.The use of lipid-based nanocarriers for targeted pain therapies.In pursuit of a moving target: nanotherapeutics for the treatment of non-Hodgkin B-cell lymphoma.Nanotechnology in the management of cervical cancer.Advances in lipid-based drug delivery: enhancing efficiency for hydrophobic drugs.Current and emerging lipid-based systems for transdermal drug delivery.Antibody-targeted biodegradable nanoparticles for cancer therapy.Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape.Technetium-99m radiolabeled paclitaxel as an imaging probe for breast cancer in vivo Lipid-based nanocarriers for the oral administration of biopharmaceutics.Recent advances on liposomal nanoparticles: synthesis, characterization and biomedical applications.Nanosized multifunctional liposomes for tumor diagnosis and molecular imaging by SPECT/CT.Cyclic hexapeptide-conjugated nanoparticles enhance curcumin delivery to glioma tumor cells and tissue.Nanomaterials for the Capture and Therapeutic Targeting of Circulating Tumor Cells.Investigation of parameters influencing incorporation, retention and cellular cytotoxicity in liposomal formulations of poorly soluble camptothecin.The use of nanoparticulates to treat breast cancer.A wogonin-loaded glycyrrhetinic acid-modified liposome for hepatic targeting with anti-tumor effects.Ultrasonic energy in liposome production: process modelling and size calculation.Surface Functionalization and Targeting Strategies of Liposomes in Solid Tumor Therapy: A Review.Targeting therapeutics to endothelium: are we there yet?Nano-liposome-based target toxicity machine: an alternative/complementary approach in atopic diseases.

P2860

Q26773160-CEB45C54-EA11-4011-BEE2-3F09EE50BA13 Q26827175-1A9487DD-AB63-4FE2-ACBF-47D35F75CAB8 Q26995399-33EB42EB-C7E5-43DB-A069-36B3E551A073 Q27314854-A3DC9BC3-E69A-4B7A-AD13-F3453353945E Q28387728-760A90F2-43B7-4F5D-B2D9-EA5F52FC044F Q28484922-4E8DD468-5023-4A7A-AE29-D204C3FEA199 Q33901479-39A4571B-D1B3-4F06-BF53-FCE340314D30 Q34674722-C84F7DEC-9EE9-45B1-A4D6-A0281E7B1473 Q35209810-EB428E6B-2D90-415E-A462-0B26B47C02C1 Q35809872-586BD123-9446-4C8F-BE5C-CE7899C7D5BC Q36110865-7CB8C963-B71D-4383-87DE-A31ECEE8B5BF Q36300321-7CE9EAC5-8ACC-4B06-B139-2723A233C0B6 Q37258973-0A9DF757-24F0-4D64-B788-F823438D7594 Q37344290-BCD0D477-1FBF-431B-B5B0-83642697526A Q38061564-850B70F1-C41A-433B-92DE-29B5A42F3DF3 Q38074445-8C228247-F772-4017-A5DF-70494F000913 Q38123854-F09BD016-5330-4F29-90BB-B3900F017C3C Q38126543-66D7A403-B259-479E-ADE6-01A1467A350B Q38127412-3F0C5904-FE85-4685-B024-CDAE13F021AB Q38167883-0E3EE790-A1F5-42A5-877C-210EF837037F Q38169707-88AB2DC2-9CDC-4213-9103-8AD01CECAF70 Q38253121-1A41A351-484D-484D-AF21-BD6217BFCAFF Q38370785-51EA9B32-EB12-4877-88C7-48351C152D08 Q38406190-28A6EB4F-2FC4-46F4-96FB-33A51E1EC778 Q38590272-887C9973-F215-4C3F-8895-CF47F96CDC04 Q38665261-A10C02A4-6B1E-4039-8B74-4A0CD73EA2CD Q38825691-047E80E6-242E-46B3-B6FA-54D0A17E6D33 Q38949920-5FB6C631-6EC1-412C-9D09-1B9E32E327B5 Q38990887-10F7463F-5627-4D0C-A2AD-EA4CF7C858CD Q39171230-6416E0E7-E2D0-4452-8291-C6A3BD522544 Q39257035-F82B0DFC-5C12-42F0-804B-475F1D8972D6 Q41415544-12253203-001B-4BC9-9C21-659812709AAF Q42339249-89E3D675-8E7D-4B14-97E6-88E5CDEE7289 Q44619320-38241717-FC48-49FE-BD6D-39EE8B796AEB Q45066468-CCBAE16C-A281-4138-AFDB-1134DFF918AE Q45356589-058ED289-C5E5-4000-9195-2E449168304F Q47178064-D67B4D63-8492-467E-A846-B34C19F0407F Q47190264-70A44F22-EAD3-4A0C-8995-65B082DB5297 Q47250590-A0480659-795B-4D87-B59E-E0A4390AC698 Q47254471-D491C536-D6DE-4624-A734-F2D64CB333B5

P2860

Challenges in development of targeted liposomal therapeutics.

http://www.wikidata.org/entity/Q37993466

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Challenges in development of targeted liposomal therapeutics.

@en

Challenges in development of targeted liposomal therapeutics.

@nl

type

label

Challenges in development of targeted liposomal therapeutics.

@en

Challenges in development of targeted liposomal therapeutics.

@nl

prefLabel

Challenges in development of targeted liposomal therapeutics.

@en

Challenges in development of targeted liposomal therapeutics.

@nl

P1433

Q37993466-8D956E91-B787-45BB-9999-206BB61DB12C

P1476

Q37993466-10634632-D49E-437D-BF7D-AE515724C73F

P2093

Q37993466-2D126ABD-1779-46C9-8E75-D6296F0F1EB5

Q37993466-B85DF689-EC0E-4087-A8DB-4D2897604FDF

P2860

Q37993466-0105FF7B-A8F1-40FA-8727-79111DA4112F

Q37993466-0249F217-543C-49FE-B148-3AF692B42253

Q37993466-02842F36-838D-4340-B42F-1B8A8B1EEE64

Q37993466-086DDDEC-CECE-46C1-9DC9-35B65700C272

Q37993466-0CD4923F-220D-4F54-A0CB-BC2FE65F65F6

Q37993466-151DE566-E9D8-4326-8168-1B2619011F0A

Q37993466-1B8B5BB1-A6DC-4EA5-BFEB-9D838EC2CD1A

Q37993466-1C9B33CA-B40C-4D1F-95A8-AA2235FC398D

Q37993466-1E31954B-7FFB-439C-9B9C-BD25351F26B1

Q37993466-21D9E934-C2BC-47AE-BBDA-E2E0E3E8D460

P2888

Q37993466-04AF491C-2B83-4ACB-A740-6B76194E7407

P304

Q37993466-8F864C06-567B-4390-9D59-1DC8EF19EF3A

P31

Q37993466-6F8E650F-1CED-4C88-ACE0-9DCCFD5E4F8F

P356

Q37993466-671B68F7-8353-4B7D-8AAC-F8435555B637

P407

Q37993466-FEFB1879-CA7D-4023-8FE9-76373A6E52BF

P433

Q37993466-68CA4291-5659-4110-B838-2CF2CC74C586

P478

Q37993466-A38223FD-FD27-4B1A-9B8B-9F805FF72BF4

P577

Q37993466-788F0C4F-BDBD-42EA-AFF9-E5860C1F8791

P5875

Q37993466-127616A6-7FAB-45E3-B36B-DB8A50A8F9BD

P6179

Q37993466-7092FBB2-1C51-46E7-B759-907D51528B2B

P698

Q37993466-ED8F0C03-7EB8-416F-AAEB-460B1E6A9829

P932

Q37993466-26CCECF6-F538-4298-A63A-2EA810AAA89B

P356

S12248-012-9330-0

P1433

The AAPS Journal

P1476

Challenges in development of targeted liposomal therapeutics.

@en

P2093

Rupa R Sawant

http://www.w3.org/2001/XMLSchema#string

Vladimir P Torchilin

http://www.w3.org/2001/XMLSchema#string

P2860

Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis

Cancer nanotechnology: opportunities and challenges

Recent advances with liposomes as pharmaceutical carriers

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

Drug delivery systems: entering the mainstream

High interstitial fluid pressure - an obstacle in cancer therapy

Tumor targeting using anti-her2 immunoliposomes.

In vitro assessment of transferrin-conjugated liposomes as drug delivery systems for inhalation therapy of lung cancer.

Impact of single-chain Fv antibody fragment affinity on nanoparticle targeting of epidermal growth factor receptor-expressing tumor cells.

A phase II study of STEALTH cisplatin (SPI-77) in patients with advanced non-small cell lung cancer.

P2888

s12248-012-9330-0

P304

303-315

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1208/S12248-012-9330-0

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221893539

http://www.w3.org/2001/XMLSchema#string

P6179

1003560139

http://www.w3.org/2001/XMLSchema#string

P698

22415612

http://www.w3.org/2001/XMLSchema#string

P932

3326155

http://www.w3.org/2001/XMLSchema#string